Reboot Rx
Reboot Rx is a nonprofit health tech startup focused on accelerating the development of affordable cancer treatments. They achieve this by repurposing existing non-cancer generic drugs, utilizing AI technology for faster identification of promising candidates, and implementing innovative funding models to support clinical trials. The company aims to overcome the market failure that hinders funding for such trials, making new treatments accessible to doctors and patients.
Reboot Rx
Reboot Rx is a nonprofit health tech startup focused on accelerating the development of affordable cancer treatments. They achieve this by repurposing existing non-cancer generic drugs, utilizing AI technology for faster identification of promising candidates, and implementing innovative funding models to support clinical trials. The company aims to overcome the market failure that hinders funding for such trials, making new treatments accessible to doctors and patients.
TL;DR
Type: Nonprofit health‑tech startup
Mission: Repurpose off‑patent generic drugs to advance affordable cancer treatments
Approach: AI‑powered evidence synthesis to identify → investigate → inform repurposing opportunities
Funding: $1,000,000 in grants announced Apr 4, 2023
Founder: Laura Kleiman, PhD (Founder & CEO)
Company Overview
Problem Domain
Market failure: promising repurposed off‑patent drugs often lack commercial sponsorship needed to fund clinical trials and reach patients.
Founded
2017
Industry
Health tech; nonprofit; oncology
Tech Stack
Funding Track Record
$1,000,000
Non‑dilutive philanthropic and institutional grants to accelerate repurposing research and development.
Investor Signal
“Early philanthropic and institutional support from Arnold Ventures, Draper Richards Kaplan Foundation, Lyda Hill Philanthropies and AWS IMAGINE Grant”